| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0968-0896(96)00107-1 |
| P698 | PubMed publication ID | 8879541 |
| P2093 | author name string | J Chen | |
| A Gazit | |||
| A Levitzki | |||
| I Chen | |||
| G McMahon | |||
| P Hirth | |||
| H App | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1203-1207 | |
| P577 | publication date | 1996-08-01 | |
| P1433 | published in | Bioorganic & Medicinal Chemistry | Q2904200 |
| P1476 | title | Tyrphostins IV--highly potent inhibitors of EGF receptor kinase. Structure-activity relationship study of 4-anilidoquinazolines | |
| P478 | volume | 4 |
| Q39783930 | Discovery and SAR of 6-substituted-4-anilinoquinazolines as non-competitive antagonists of mGlu5. |
| Q34088024 | Drug-induced ubiquitylation and degradation of ErbB receptor tyrosine kinases: implications for cancer therapy |
| Q33746958 | Inhibiting the function of ABCB1 and ABCG2 by the EGFR tyrosine kinase inhibitor AG1478 |
| Q33716113 | Inhibition of the epidermal growth factor receptor family of tyrosine kinases as an approach to cancer chemotherapy: progression from reversible to irreversible inhibitors |
| Q33957454 | Neu differentiation factor stimulates phosphorylation and activation of the Sp1 transcription factor |
| Q33618341 | Novel effects of Brefeldin A (BFA) in signaling through the insulin receptor (IR) pathway and regulating FoxO1-mediated transcription |
| Q40800760 | Potential (18)F-labeled biomarkers for epidermal growth factor receptor tyrosine kinase. |
| Q33716122 | Protein tyrosine kinase inhibitors as novel therapeutic agents |
| Q33188385 | Studies of ligand-induced site-specific phosphorylation of epidermal growth factor receptor |
| Q44328420 | The pp60c-Src inhibitor PP1 is non-competitive against ATP. |
| Q35045444 | Tyrosine kinases as targets for cancer therapy |
| Q42799393 | Tyrphostin AG 494 blocks Cdk2 activation |
| Q40592568 | Tyrphostin AG1478 Inhibits Encephalomyocarditis Virus and Hepatitis C Virus by Targeting Phosphatidylinositol 4-Kinase IIIα. |
| Q29617290 | Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1 |
| Q42518739 | c-Src activation by the E5 oncoprotein enables transformation independently of PDGF receptor activation |
Search more.